Potassium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an essential electrolyte used to treat and prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment of hypokalemia. * Prevention of hypokalemia, particularly in patients receiving diuretics that waste potassium or those with inadequate dietary intake. ## Adult Dosing * **Oral Replacement:** * **Mild hypokalemia (3.0-3.4 mEq/L):** 20 mEq once daily. * **Moderate hypokalemia (2.5-2.9 mEq/L):** 40 mEq once daily or 20 mEq twice daily. * **Severe hypokalemia (<2.5 mEq/L):** 40-100 mEq daily in divided doses. * **Maintenance:** 10-20 mEq daily. * *Maximum oral dose:* Generally, 100 mEq/day, but may be higher under strict medical supervision. Doses exceeding 20 mEq in a single oral administration require dilution or slower administration. * **Intravenous (IV) Replacement:** * **Mild to moderate hypokalemia:** Typically administered at rates of 10-20 mEq/hour. * **Severe hypokalemia or rapid correction:** May be administered at rates up to 40 mEq/hour, but only with continuous cardiac monitoring in an ICU setting. * *Maximum IV concentration:* Do not exceed 40 mEq/L in peripheral lines to minimize phlebitis. Higher concentrations (up to 100 mEq/L) may be used in central lines with rapid infusion rates, but only in critical care settings with continuous cardiac monitoring. * *Maximum IV dose:* Generally, 400 mEq/day, but higher doses may be required in severe, life-threatening hypokalemia under intensive monitoring. ## Pediatric Dosing * **Oral Replacement:** * **Maintenance:** 2-3 mEq/kg/day, divided into 2-4 doses, not to exceed 40 mEq/day. * **Correction:** Dosing should be guided by serum potassium levels and clinical assessment. Usual doses range from 0.5-1 mEq/kg/dose. * **Intravenous (IV) Replacement:** * **Maintenance:** 20-30 mEq/L in IV fluids. * **Correction:** Rates typically 0.3-0.5 mEq/kg/hour. * *Maximum IV concentration:* 40 mEq/L in peripheral lines. * *Maximum IV dose:* 20 mEq per dose, not to exceed 40 mEq/day in infants or 100 mEq/day in older children, with careful monitoring. Higher doses may be necessary in severe cases under strict monitoring. ## Dose Adjustments * **Renal Impairment:** Use with extreme caution. Reduce dose and monitor potassium levels closely, as impaired renal function can lead to hyperkalemia. * **Adrenal Insufficiency:** May require lower doses. ## Contraindications * Hyperkalemia (serum potassium >5.0 mEq/L). * Conditions that predispose to hyperkalemia, such as severe renal impairment, untreated Addison's disease, anuria, or certain arrhythmias. * Known hypersensitivity to potassium chloride. * Gastrointestinal obstruction or delayed gastric emptying. ## Adverse Effects * **Hyperkalemia:** The most serious adverse effect, characterized by muscle weakness, fatigue, paresthesias, paralysis, cardiac arrhythmias, and cardiac arrest. * **Gastrointestinal (oral):** Nausea, vomiting, abdominal pain, diarrhea, and gastrointestinal bleeding or perforation (especially with undiluted or slow-release formulations). * **Vein irritation/phlebitis (IV):** Especially with higher concentrations or rapid infusions. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors and ARBs:** Can increase serum potassium, increasing the risk of hyperkalemia. * **NSAIDs:** May decrease potassium excretion, increasing risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase digoxin toxicity; hypokalemia can enhance digoxin toxicity. * **Salt substitutes:** Often contain potassium chloride, increasing the risk of hyperkalemia if used concurrently with potassium supplements. ## Monitoring * **Serum potassium levels:** Monitor frequently, especially during initiation of therapy, dose changes, and in patients with impaired renal function or risk factors for hyperkalemia. Frequency depends on severity of hypokalemia and clinical status. * **Renal function (BUN, creatinine):** Essential for dose adjustment. * **ECG:** Particularly important with IV administration, rapid correction, or in patients with cardiac disease, to monitor for signs of hyperkalemia (e.g., peaked T waves, widening QRS). * **Signs and symptoms of hypokalemia and hyperkalemia.** ## Clinical Pearls * Always dilute oral potassium chloride solutions before administration to reduce gastrointestinal irritation and risk of ulceration. * Slow-release oral formulations should be swallowed whole and not chewed or crushed. * Intravenous potassium chloride is a vesicant and must be administered with caution. Central venous access is preferred for higher concentrations or rapid infusions. * Ensure adequate urine output before initiating or increasing IV potassium replacement. * When correcting severe hypokalemia, especially with IV potassium, continuous cardiac monitoring is crucial. *** *Disclaimer: This information is intended for healthcare professionals. Always consult the official prescribing information and relevant clinical guidelines for the most current and comprehensive details, as individual patient needs and local protocols may vary.*